Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as GBX 1.57 ($0.02) and last traded at GBX 1.70 ($0.02), with a volume of 3418268 shares trading hands. The stock had previously closed at GBX 1.70 ($0.02).
Cizzle Biotechnology Stock Performance
The company has a 50 day simple moving average of GBX 1.95 and a 200 day simple moving average of GBX 2.11. The stock has a market cap of £6.74 million, a P/E ratio of 170.00 and a beta of 0.35.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
See Also
- Five stocks we like better than Cizzle Biotechnology
- Dividend Payout Ratio Calculator
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- The 3 Best Fintech Stocks to Buy Now
- Generac Powers Ahead on the Electrification Mega-Trend
- NYSE Stocks Give Investors a Variety of Quality Options
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
